Home › Lipoid Nephrosis › Illinois
Lipoid Nephrosis clinical trials in Illinois
4 studies for Lipoid Nephrosis are looking for participants at sites in Illinois.
Cities in Illinois
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Northwestern Memorial Hospital- Site Number : 8400014, Chicago
- Nephrology Associates of Northern Illinois and Indiana (NANI) - Hinsdale- Site Number : 8400017, Hinsdale
RecruitingPhase 2
Ages 16 to 75 · All sexes · Updated Sep 23, 2026 · NCT06500702Study of WAL0921 in Patients With Glomerular Kidney Diseases
- Nephrology Associates of Northern Illinois and Indiana (NANI), Hinsdale
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT06466135NEPTUNE Match Study
- John H. Stroger, Jr., Hospital of Cook County, Chicago
Recruiting
Ages 1 to 80 · All sexes · Updated Jun 10, 2026 · NCT04571658Nephrotic Syndrome Study Network
- John Stroger Cook County Hospital, Chicago
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.